Developed analytical strategies for characterizing and establishing structural sameness of API with Reference Listed Drug (RLD) for generic peptides and complex molecules. Contributed to the preparation of US Drug Master File (DMF) submissions for three peptide molecules.Knowledge of global CMC regulatory requirements and life cycle management.

Leading structure elucidation team that handles characterization of therapeutic peptides and complex molecules using state-of-the-art analytical techniques like NMR, HRMS, CD, IR, SV-AUC, SEC-MALS

Trained postgraduate students of Pharmacy in Modern Analytical Techniques and Biopharmaceutics.

Conceptualized and authored the project proposal that resulted in an award of Rs. 20,00,000/- research grant by Department of Science and Technology, Government of India, for a period of three years. Published for the first time, the 15N NMR at natural abundance, for twenty-two out of twenty-three molecules studied. Ten other molecules were attempted. Investigated novel use of 15N-NMR chemical shifts to investigate structure-activity relationships.

Bioinformatics support for development /evaluation of prokaryotic gene prediction programs. Analyzed DNA/protein sequences using different programs like BLAST, Pfam, Interpro, SCOP, etc.

Consultant for Drug Discovery R&D Informatics - Implemented Activity base, a platform for screening data management and trained scientists on the tool.

Developed methods and analyzed different dosage forms using various analytical techniques like HPLC, UV, IR, dissolution and GC. Developed two oral solid dosage forms, containing single and multiple active pharmaceutical ingredients.